Literature DB >> 19406058

[Positron emission tomography/computed tomography with 18F-FDG. PET Working Group. Procedures Committee of the Spanish Society of Nuclear Medicine].

J R García Garzón1, A Rodríguez, A Cabrera.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19406058     DOI： 10.1016/s0212-6982(09)70706-2

Source DB:  PubMed          Journal:  Rev Esp Med Nucl        ISSN： 0212-6982


× No keyword cloud information.
  7 in total

1.  Recommendations of the Spanish Societies of Radiation Oncology (SEOR), Nuclear Medicine & Molecular Imaging (SEMNiM), and Medical Physics (SEFM) on (18)F-FDG PET-CT for radiotherapy treatment planning.

Authors:  Begoña Caballero Perea; Antonio Cabrera Villegas; José Miguel Delgado Rodríguez; María José García Velloso; Ana María García Vicente; Carlos Huerga Cabrerizo; Rosa Morera López; Luis Alberto Pérez Romasanta; Moisés Sáez Beltrán
Journal:  Rep Pract Oncol Radiother       Date:  2012-11-17

2.  Early and delayed prediction of axillary lymph node neoadjuvant response by (18)F-FDG PET/CT in patients with locally advanced breast cancer.

Authors:  Ana María García Vicente; Ángel Soriano Castrejón; Alberto León Martín; Fernanda Relea Calatayud; María Del Mar Muñoz Sánchez; Miguel Ángel Cruz Mora; Germán Andrés Jiménez Londoño; Ruth Espinosa Aunión
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04-18       Impact factor: 9.236

3.  Semi-quantitative lymph node assessment of (18)F-FDG PET/CT in locally advanced breast cancer: correlation with biological prognostic factors.

Authors:  Ana María García Vicente; Angel Soriano Castrejón; Miguel Angel Cruz Mora; Ana González Ageitos; María del Mar Muñoz Sánchez; Alberto León Martín; Ruth Espinosa Aunión; Fernanda Relea Calatayud; Vicente Muñoz Madero; Ignacio Chacón López-Muñiz; Jose Manuel Cordero García; Germán Andrés Jiménez Londoño
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-09-28       Impact factor: 9.236

4.  Glycolytic activity with 18F-FDG PET/CT predicts final neoadjuvant chemotherapy response in breast cancer.

Authors:  Ana María García Vicente; Miguel Ángel Cruz Mora; Antonio Alberto León Martín; María Del Mar Muñoz Sánchez; Fernanda Relea Calatayud; Ober Van Gómez López; Ruth Espinosa Aunión; Ana Gonzalez Ageitos; Angel Soriano Castrejón
Journal:  Tumour Biol       Date:  2014-08-20

5.  [18F]FDG PET/CT in Short-Term Complications of COVID-19: Metabolic Markers of Persistent Inflammation and Impaired Respiratory Function.

Authors:  Eva María Triviño-Ibáñez; Beatriz María Jiménez-Rodríguez; Teodoro Rudolphi-Solero; Encarnación Yolanda García-Rivero; Antonio Rodríguez-Fernández; José Manuel Llamas-Elvira; Manuel Gómez-Río; Concepción Morales-García
Journal:  Diagnostics (Basel)       Date:  2022-03-29

6.  Molecular subtypes of breast cancer: metabolic correlation with ¹⁸F-FDG PET/CT.

Authors:  Ana María García Vicente; Ángel Soriano Castrejón; Alberto León Martín; Ignacio Chacón López-Muñiz; Vicente Muñoz Madero; María del Mar Muñoz Sánchez; Azahara Palomar Muñoz; Ruth Espinosa Aunión; Ana González Ageitos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-30       Impact factor: 9.236

7.  [18F]-FDG PET/CT in oncologic patients with unsuspected asymptomatic infection with SARS-CoV-2.

Authors:  Antonio Cabrera Villegas; Leonardo G Romero Robles; Xavier L E Boulvard Chollet; M Clara Albornoz Almada; María Mangas Losada; Puy Garrastachu; Francisco M Cañete Sánchez; Rafael Ramírez Lasanta; Roberto C Delgado Bolton
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-09-16       Impact factor: 9.236
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.